Home
Gilead and Eisai Submitted an Application to Japan’s PMDA for Approval of Filgotinib for UC

Gilead and Eisai Submitted an Application to Japan’s PMDA for Approval of Filgotinib for UC

Today’s Highlights April 23, 2021

Gilead Sciences and Eisai Pharmaceutical Co Submitted an Application to Japan's PMDA for Filgotinib
Galapagos NV (GLPG) announced that Gilead Sciences (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
, ,
April 23, 2021

Other Articles